Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR7044(2)] to MIP-3 beta/CCL19 - BSA and Azide free
  • Suitable for: WB, Flow Cyt
  • Reacts with: Human

Overview

  • Product name

    Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free
    See all MIP-3 beta/CCL19 primary antibodies

  • Description

    Rabbit monoclonal [EPR7044(2)] to MIP-3 beta/CCL19 - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    WB
    Human
    See all applications and species data

  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • General notes

    ab251159 is the carrier-free version of ab192877 This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    Ab251159 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product was previously labelled as Macrophage Inflammatory Protein 3 beta

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Flow Cytometry - Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)
    Flow Cytometry - Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)
    This data was developed using ab192877, the same antibody clone in a different buffer formulation.Flow cytometric analysis of 2% paraformaldehyde-fixed A549 cells labeling MIP-3 beta/CCL19 with ab192877 at 1/170 dilution (red) compared with a rabbit monoclonal IgG isotype control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.
  • Western blot - Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)
    Western blot - Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)
    Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] (ab192877) at 1/20000 dilution + Human MIP-3 beta/CCL19 recombinant protein (aa22-98) at 10 µg

    Secondary
    Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

    Predicted band size: 11 kDa
    Observed band size: 11 kDa



    This data was developed using ab192877, the same antibody clone in a different buffer formulation.

    Blocking and dilution buffer: 5% NFDM/TBST.

  • Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)
    Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-MIP-3 beta/CCL19 antibody [EPR7044(2)] - BSA and Azide free (ab251159)

© 2021 Astana Biomed Group LLP. All rights reserved.